Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial

Front Public Health. 2023 Nov 22:11:1234765. doi: 10.3389/fpubh.2023.1234765. eCollection 2023.

Abstract

Aims: To study the effect of inhaled cannabis on self-assessed predicted driving ability and its relation to reaction times and driving ability on a driving simulator.

Participants and methods: 30 healthy male volunteers aged 18-34: 15 chronic (1-2 joints /day) and 15 occasional (1-2 joints/week) consumers. Self-assessed driving confidence (visual analog scale), vigilance (Karolinska), reaction time (mean reciprocal reaction time mRRT, psychomotor vigilance test), driving ability (standard deviation of lane position SDLP on a York driving simulator) and blood concentrations of delta-9-tétrahydrocannabinol (THC) were measured before and repeatedly after controlled inhalation of placebo, 10 mg or 30 mg of THC mixed with tobacco in a cigarette.

Results: Cannabis consumption (at 10 and 30 mg) led to a marked decrease in driving confidence over the first 2 h which remained below baseline at 8 h. Driving confidence was related to THC dose and to THC concentrations in the effective compartment with a low concentration of 0.11 ng/ml for the EC50 and a rapid onset of action (T1/2 37 min). Driving ability and reaction times were reduced by cannabis consumption. Driving confidence was shown to be related to driving ability and reaction times in both chronic and occasional consumers.

Conclusions: Cannabis consumption leads to a rapid reduction in driving confidence which is related to reduced ability on a driving simulator.

Clinical trial registration: ClinicalTrials.gov, identifier: NCT02061020.

Keywords: accident; cannabis; driving; driving simulator; reaction time.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Automobile Driving*
  • Cannabis*
  • Dronabinol / pharmacology
  • Humans
  • Male
  • Marijuana Smoking*
  • Psychomotor Performance

Substances

  • Dronabinol

Associated data

  • ClinicalTrials.gov/NCT02061020

Grants and funding

The Assistance Publique - Hôpitaux de Paris and a grant from the French Ministry of Health (PHRC Programme Hospitalier de Recherche Clinique grant number AOR12144).